World Intellectual Property Organization

Roundtable Discussion - WIPO Re:Search – Sharing Innovation in the Fight Against Neglected Tropical Diseases

October 26, 2011, 2 p.m. to 3.30 pm – WIPO, 34, chemin des Colombettes, Geneva, Room A

Finding cures and better treatments for Neglected Tropical Diseases (NTDs), malaria, and tuberculosis is an important global health priority. There are a number of private and public sector initiatives to address the challenge of these diseases. Yet, more research can be stimulated by increasing access to intellectual property (IP) developed by institutions worldwide.

WIPO Re:Search is a consortium of public and private sector organizations coming together to encourage research and development of medicines, vaccines and diagnostics for NTDs, malaria and tuberculosis. The objective of its members is to leverage their IP assets, including relevant services, to facilitate the discovery of new solutions for these diseases.

Through WIPO Re:Search, qualified researchers will have access under license to IP for pharmaceutical compounds, technologies, know-how and data to support R&D for NTDs, tuberculosis, and malaria. By providing a searchable, public database of available IP assets and resources, WIPO Re:Search will facilitate and encourage new partnerships among organizations that conduct research on NTDs, ultimately improving the lives of those most in need.

You are welcome to join the launch event for WIPO Re:Search, which will be held at WIPO’s headquarters, in Room A, on October 26, 2011, from 2 p.m. to 3.30 p.m. It will include a roundtable discussion chaired by Mr. Francis Gurry, Director General of WIPO, with the participation of Mrs. Margaret Chan, Director General of WHO, and other distinguished guests representing members of the consortium. Participation is invited from WIPO Member States and observers who are accredited at WIPO, and interested individuals and organizations.

This event is available via a live webcast: http://www.bvgh.org/WIPO-ReSearch-Webcast.aspx

It will be held in English; simultaneous interpretation will be provided in French and Spanish.

 

Explore WIPO